Theracurmin®

Drinkable preparation of Theracurmin exhibits high absorption efficiency–a single-dose, double-blind, 4-way crossover study.

Morimoto T, Sunagawa Y, Katanasaka Y, Hirano S, Namiki M, Watanabe Y, Suzuki H, Doi O, Suzuki K, Yamauchi M, Yokoji T, Miyoshi-Morimoto E, Otsuka Y, Hamada T, Imaizumi A, Nonaka Y, Fuwa T, Teramoto T, Kakeya H, Wada H, Hasegawa K.

Biol Pharm Bull. 2013; 36 (11): 1708-1714.

Safety Evaluation of Theracurmin® in Healthy Japanese Adults. ―A Randomized, Double-blind, Placebo-controlled Parallel-group Study―

Takahashi T, Iio S, Takara T.

Jpn Pharmacol Thervol. 2019 Jul 1; 47(7): 1097-1113.

Innovative preparation of curcumin for improved oral bioavailability.

Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T.

Biol Pharm Bull. 2011; 34 (5): 660-665.

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T.

Cancer Chemother Pharmacol. 2012 Jan; 69 (1): 65-70.

The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain.

Erken N, Dost Gunay FS, Soysal P, Isik AT.

Clin Interv Aging. 2020 May 19;15:691-693. doi: 10.2147/CIA.S252229. eCollection 2020.

Highly bioavailable curcumin (Theracurmin): its development and clinical application.

Imaizumi A.

PharmaNutrition. 2015 Oct; 3 (4): 123–130.